
    
      A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety and Tolerability of
      GTS-21 (25 Mg TID, 50 Mg TID, 75 Mg TID and 150 Mg TID) When Administered Daily for 28 Days
      to Participants With Probable Alzheimer's Disease
    
  